Difference between revisions of "Team:ETH Zurich/Achievements"

Line 21: Line 21:
 
<ul>
 
<ul>
  
<li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">We completed the Judging Form</li>
+
<li>We completed the Judging Form</li>
<li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">We created a <a href="https://2015.igem.org/Team:ETH_Zurich/Description">description of our project</a> in time and documented each aspect of the project on this page.</li>
+
<li>We created a <a href="https://2015.igem.org/Team:ETH_Zurich/Description">description of our project</a> in time and documented each aspect of the project on this page.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">Documented 20 parts taken from the <a href="https://2015.igem.org/Team:ETH_Zurich/Parts"> Registry of Standard Biological Parts</a>.</li>
+
<li>Documented 20 parts taken from the <a href="https://2015.igem.org/Team:ETH_Zurich/Parts"> Registry of Standard Biological Parts</a>.</li>
  
 
</ul>
 
</ul>
Line 39: Line 39:
 
<li>We implemented a method to do single cell analysis of cancer cells by <a href="https://2015.igem.org/Team:ETH_Zurich/Design#System_Overview">expressing Annexin V in the <i> E. coli</i> outer membrane</a>, which enables them to selectively bind to apoptotic cancer cells.</li>
 
<li>We implemented a method to do single cell analysis of cancer cells by <a href="https://2015.igem.org/Team:ETH_Zurich/Design#System_Overview">expressing Annexin V in the <i> E. coli</i> outer membrane</a>, which enables them to selectively bind to apoptotic cancer cells.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">We designed 8 synthetic <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">LldR dependent promoters</a> and characterized them. Additionally, the influence of the lacate importer LldP was characterized.</li>
+
<li>We designed 8 synthetic <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">LldR dependent promoters</a> and characterized them. Additionally, the influence of the lacate importer LldP was characterized.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/e/e8/ETH15_Silver_medal.png" align="right" width="1.8%">We documented and submitted two new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with 14 parts.</li>
+
<li>We documented and submitted two new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with 14 parts.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a limited amount of information present in the Parts Registry and in the literature.</li>
+
<li>We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a limited amount of information present in the Parts Registry and in the literature.</li>
  
 
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for future application of our MicroBeacon <i>E. coli</i>.</li>
 
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for future application of our MicroBeacon <i>E. coli</i>.</li>
Line 58: Line 58:
 
<li>We separately modeled two different signals of our cancer detection system, the <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">Lactate Module</a> and the <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module"> AHL Module</a>.</li>
 
<li>We separately modeled two different signals of our cancer detection system, the <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">Lactate Module</a> and the <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module"> AHL Module</a>.</li>
  
<li> We defined and estimated <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Parameters">all relevant parameters for our models</a>.</li>
+
<li>We defined and estimated <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Parameters">all relevant parameters for our models</a>.</li>
  
 
<li>We integrated the two modules into a <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Single-cell_Model">Combined Compartment Model</a> to simulate a logical AND gate.</li>
 
<li>We integrated the two modules into a <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Single-cell_Model">Combined Compartment Model</a> to simulate a logical AND gate.</li>
Line 75: Line 75:
 
<ul>
 
<ul>
  
<li><img src="https://static.igem.org/mediawiki/2015/e/e8/ETH15_Silver_medal.png" align="right" width="1.8%">We went to two different schools, thaught the children about what DNA is, performed experiments with them and published an <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Awareness#_Newspaper_Articles_">article about it in the local newspaper</a>.</li>
+
<li>We went to two different schools, thaught the children about what DNA is, performed experiments with them and published an <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Awareness#_Newspaper_Articles_">article about it in the local newspaper</a>.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/e/e8/ETH15_Silver_medal.png" align="right" width="1.8%">We told the ETH-student magacine <a href="http://www.vseth.ethz.ch/polykum/archiv#2014/2015">polykum</a> about iGEM and gave an interview.</li>
+
<li>We told the ETH-student magacine <a href="http://www.vseth.ethz.ch/polykum/archiv#2014/2015">polykum</a> about iGEM and gave an interview.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Stockholm">collaborated</a> with the team from <a href="https://2015.igem.org/Team:Stockholm"> Stockholm</a> by testing some of their constructs.</li>
+
<li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Stockholm">collaborated</a> with the team from <a href="https://2015.igem.org/Team:Stockholm"> Stockholm</a> by testing some of their constructs.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Amoy">contributed</a> to the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno1?e=17843433/13214508">Newsletters</a> from <a href="https://2015.igem.org/Team:Amoy#">Amoys team</a>, met with the <a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt team</a>, helped with a survey from <a href="https://2015.igem.org/Team:EPF_Lausanne">EPFL</a> and provided <a href="https://2015.igem.org/Team:Uniandes_Colombia">Colombias team</a> with protocols and <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Colombia">advice</a> when their transformations did not work.</li>
+
<li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Amoy">contributed</a> to the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno1?e=17843433/13214508">Newsletters</a> from <a href="https://2015.igem.org/Team:Amoy#">Amoys team</a>, met with the <a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt team</a>, helped with a survey from <a href="https://2015.igem.org/Team:EPF_Lausanne">EPFL</a> and provided <a href="https://2015.igem.org/Team:Uniandes_Colombia">Colombias team</a> with protocols and <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Colombia">advice</a> when their transformations did not work.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We <a href="https://2015.igem.org/Team:ETH_Zurich/Practices">interviewed many different experts</a> from various fields, such as <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Medicine">medical doctors</a>,  <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Ethics">somebody from the ethics commission</a>, the <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Business">founder of a start-up</a> or an  <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Patents">expert in patents law</a> and <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Influence_of_human_practices">integrated the advice and ideas</a> we got from them into the <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Design">design</a>.</li>
+
<li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Practices">interviewed many different experts</a> from various fields, such as <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Medicine">medical doctors</a>,  <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Ethics">somebody from the ethics commission</a>, the <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Business">founder of a start-up</a> or an  <a href="https://2015.igem.org/Team:ETH_Zurich/Practices/Patents">expert in patents law</a> and <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Influence_of_human_practices">integrated the advice and ideas</a> we got from them into the <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Design">design</a>.</li>
 
</ul>
 
</ul>
 
<p></p>
 
<p></p>

Revision as of 09:38, 18 September 2015

"What I cannot create I do not understand."
- Richard Feynmann

Achievements

We are proud to announce that we achieved the following goals

General Achievements

Experimental Achievements

  • We designed a novel system for detection of circulating tumour cells in blood samples using genetically modified bacteria.
  • We designed a genetic circuit that integrates two different cancer specific signals (lactate and AHL)in an AND gate.
  • We implemented a method to do single cell analysis of cancer cells by expressing Annexin V in the E. coli outer membrane, which enables them to selectively bind to apoptotic cancer cells.
  • We designed 8 synthetic LldR dependent promoters and characterized them. Additionally, the influence of the lacate importer LldP was characterized.
  • We documented and submitted two new basic parts to the iGEM parts registry and created a part collection with 14 parts.
  • We characterized parts of the natural E. coli lldPRD-operon, on which there is only a limited amount of information present in the Parts Registry and in the literature.
  • We designed a chip for future application of our MicroBeacon E. coli.
  • We participated in the interlab study.
  • Our experiments complied with the safety instructions at the Department of Biosystems Science and Engineering D-BSSE in Basel where our lab is situated.

Modeling Achievements

Human Practices Achievements

Medal Criteria

We registered for iGEM, had a great summer so far, and now we are looking forward to attending the Giant Jamboree! Going for it!
We completed and submitted the Judging Form
We created a description of our project in time.
We documented all the parts taken from the Registry of Standard Biological Parts
We are going to present a poster and give a talk at the Giant Jamboree. Going for it!
We created this website for you to learn about every aspect of our iGEM project.
We documented and submitted two new basic parts to the iGEM parts registry and created a part collection with 14 parts.
Experimentally validate that at least one new BioBrick Part of your own design
These new parts we also submitted to the iGEM Parts Registry.
Human Practices in iGEM. Demonstrate how your team has identified, investigated and addressed one or more of these issues in the context of your project.
Expand on your silver medal Human Practices activity
Help another university to characterize a part
Improve the characterization of a previously existing BioBrick Part or Device

We would like to thank our sponsors